All In Biotech

Investigational drug · Phase 3

folinic acid

Not approved by FDA. In 4 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer.

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

4

4 still active

All registered trials

2,289

Any phase or sponsor naming "folinic acid"

First trial start

2018

Jun 21, 2018

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "folinic acid", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Unresectable Metastatic Colorectal Cancer
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
  • Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
  • Metastatic Gastric Adenocarcinoma or Cancer
  • Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Pharmacokinetics of Zolbetuximab
  • Gastric Cancer
  • Gastro-esophageal Junction (GEJ) Cancer
  • Pharmacokinetics of Oxaliplatin
  • Pharmacokinetics of Fluorouracil Bolus (5-FU)

Approved drugs for the same conditions: Colorectal cancer · Stomach and esophageal cancer · Oncology · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "folinic acid" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 3,594 on PubMed

Also in development for Unresectable Metastatic Colorectal Cancer

  • Telisotuzumab AdizutecanABBV-400Phase 316 trials

    AbbVie · c-MET, Non-Squamous Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer

  • STC-1010Phase 21 trial

    Brenus Pharma · Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Astellas.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.